{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:55:27Z","timestamp":1792173327709,"version":"4.4.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["semradonc.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Radiation Oncology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.semradonc.2017.04.002","type":"journal-article","created":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T00:49:51Z","timestamp":1504486191000},"page":"350-357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["Radiation-Induced Liver Toxicity"],"prefix":"10.1016","volume":"27","author":[{"given":"Pablo","family":"Munoz-Schuffenegger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semradonc.2017.04.002_bib1","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.semradonc.2011.05.003","article-title":"Hepatic radiation toxicity: Avoidance and amelioration","volume":"21","author":"Guha","year":"2011","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.semradonc.2017.04.002_bib2","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0360-3016(94)00418-K","article-title":"Hepatic toxicity resulting from cancer treatment","volume":"31","author":"Lawrence","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2017.04.002_bib3","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/annonc\/mdh095","article-title":"Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer","volume":"15","author":"Rubbia-Brandt","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.semradonc.2017.04.002_bib4","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.2005.05.3074","article-title":"Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases","volume":"24","author":"Vauthey","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2017.04.002_bib5","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/00000658-200012000-00006","article-title":"Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors","volume":"232","author":"Adam","year":"2000","journal-title":"Ann Surg"},{"key":"10.1016\/j.semradonc.2017.04.002_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0167-8140(02)00061-0","article-title":"Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma: Clinical manifestation and dosimetric description","volume":"63","author":"Cheng","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2017.04.002_bib7","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ijrobp.2005.12.031","article-title":"Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: The risk factors and hepatic radiation tolerance","volume":"65","author":"Liang","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2017.04.002_bib8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.radonc.2016.10.024","article-title":"Central liver toxicity after SBRT: An expanded analysis and predictive nomogram","volume":"122","author":"Toesca","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2017.04.002_bib9","first-page":"584","article-title":"Pathogenesis of veno-occlusive liver disease after radiation","volume":"104","author":"Fajardo","year":"1980","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.semradonc.2017.04.002_bib10","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.ijrobp.2008.07.032","article-title":"Microscopic and macroscopic tumor and parenchymal effects of liver stereotactic body radiotherapy","volume":"73","author":"Olsen","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2017.04.002_bib11","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1158\/1078-0432.CCR-06-2459","article-title":"Radiation-induced hepatitis B virus reactivation in liver mediated by the bystander effect from irradiated endothelial cells","volume":"13","author":"Chou","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.semradonc.2017.04.002_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2307\/3577586","article-title":"Transforming growth factor-beta 1 expression in irradiated liver","volume":"122","author":"Anscher","year":"1990","journal-title":"Radiat Res"},{"key":"10.1016\/j.semradonc.2017.04.002_bib13","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0360-3016(99)00401-0","article-title":"Early alteration in TGF-beta mRNA expression in irradiated rat liver","volume":"46","author":"Seong","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2017.04.002_bib14","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s12072-014-9532-x","article-title":"Hedgehog signaling and radiation induced liver injury: A delicate balance","volume":"8","author":"Kabarriti","year":"2014","journal-title":"Hepatol Int."},{"key":"10.1016\/j.semradonc.2017.04.002_bib15","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jhep.2010.10.003","article-title":"Hedgehog signaling in the liver","volume":"54","author":"Omenetti","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.semradonc.2017.04.002_bib16","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/hep.23525","article-title":"Hedgehog signaling is critical for normal liver regeneration after partial hepatectomy in mice","volume":"51","author":"Ochoa","year":"2010","journal-title":"Hepatology."},{"key":"10.1016\/j.semradonc.2017.04.002_bib17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1667\/RR3091.1","article-title":"Hedgehog signaling regulates the repair response in mouse liver damaged by irradiation","volume":"179","author":"Wang","year":"2013","journal-title":"Radiat Res"},{"key":"10.1016\/j.semradonc.2017.04.002_bib18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0232-1513(88)80155-5","article-title":"Thioacetamide-induced cirrhosis-like liver lesions in rats\u2014usefulness and reliability of this animal model","volume":"34","author":"Muller","year":"1988","journal-title":"Exp Pathol"},{"key":"10.1016\/j.semradonc.2017.04.002_bib19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1440-1746.1992.tb00940.x","article-title":"Carbon tetrachloride induced cirrhosis in rats: A useful tool for investigating the pathogenesis of ascites in chronic liver disease","volume":"7","author":"Jimenez","year":"1992","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.semradonc.2017.04.002_bib20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2613.2009.00656.x","article-title":"Experimental mouse models for hepatocellular carcinoma research","volume":"90","author":"Heindryckx","year":"2009","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.semradonc.2017.04.002_bib21","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2307\/3578033","article-title":"Radiation hepatology of the rat: Microvascular fibrosis and enhancement of liver dysfunction by diet and drugs","volume":"129","author":"Geraci","year":"1992","journal-title":"Radiat Res"},{"key":"10.1016\/j.semradonc.2017.04.002_bib22","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ijrobp.2013.10.037","article-title":"A nonhuman primate model of human radiation-induced venocclusive liver disease and hepatocyte injury","volume":"88","author":"Yannam","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2017.04.002_bib23","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/jrr\/rru005","article-title":"Long-term pathological and immunohistochemical features in the liver after intraoperative whole-liver irradiation in rats","volume":"55","author":"Imaeda","year":"2014","journal-title":"J Radiat Res"},{"key":"10.1016\/j.semradonc.2017.04.002_bib24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1118\/1.4889707","article-title":"SU-C-BRE-01: 3D conformal micro irradiation results of four treatment sites for preclinical small animal and clinical treatment plans","volume":"41","author":"Price","year":"2014","journal-title":"Med Phys"},{"key":"10.1016\/j.semradonc.2017.04.002_bib25","first-page":"1","article-title":"Surgery and portal hypertension","volume":"1","author":"Child","year":"1964","journal-title":"Major Probl Clin Surg"},{"key":"10.1016\/j.semradonc.2017.04.002_bib26","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.semradonc.2017.04.002_bib27","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver-transplant waiting list","volume":"359","author":"Kim","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2017.04.002_bib28","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: A new evidence-based approach-the ALBI grade","volume":"33","author":"Johnson","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2017.04.002_bib29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.prro.2016.10.003","article-title":"Assessment of hepatic function decline after stereotactic body radiation therapy for primary liver cancer","volume":"7","author":"Toesca","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.semradonc.2017.04.002_bib30","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0360-3016(02)02846-8","article-title":"Analysis of radiation-induced liver disease using the Lyman NTCP model","volume":"53","author":"Dawson","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2017.04.002_bib31","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.ijrobp.2009.06.092","article-title":"Radiation-associated liver injury","volume":"76","author":"Pan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2017.04.002_bib32","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1080\/02841860600904854","article-title":"Phase II study on stereotactic body radiotherapy of colorectal metastases","volume":"45","author":"Hoyer","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.semradonc.2017.04.002_bib33","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1200\/JCO.2008.20.0600","article-title":"Phase I study of individualized stereotactic body radiotherapy of liver metastases","volume":"27","author":"Lee","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2017.04.002_bib34","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1080\/02841860600904870","article-title":"Interim analysis of a prospective phase I\/II trial of SBRT for liver metastases","volume":"45","author":"Kavanagh","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.semradonc.2017.04.002_bib35","doi-asserted-by":"crossref","first-page":"E201","DOI":"10.1016\/j.ijrobp.2016.06.1098","article-title":"Dosimetric associations with acute liver toxicity in stereotactic body radiation therapy for liver metastases","volume":"96","author":"Barry","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2017.04.002_bib36","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3346\/jkms.2015.30.8.1055","article-title":"Low hepatic toxicity in primary and metastatic liver cancers after stereotactic ablative radiotherapy using 3 fractions","volume":"30","author":"Bae","year":"2015","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.semradonc.2017.04.002_bib37","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1200\/JCO.2012.44.1659","article-title":"Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma","volume":"31","author":"Bujold","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2017.04.002_bib38","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ijrobp.2009.09.009","article-title":"Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: Dose-volumetric parameters predicting the hepatic complication","volume":"78","author":"Son","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2017.04.002_bib39","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.prro.2014.09.007","article-title":"Effect of high-dose stereotactic body radiation therapy on liver function in the treatment of primary and metastatic liver malignancies using the Child-Pugh score classification system","volume":"5","author":"Dyk","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.semradonc.2017.04.002_bib40","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1016\/j.prro.2015.02.007","article-title":"Treatment variables related to liver toxicity in patients with hepatocellular carcinoma, Child-Pugh class A and B enrolled in a phase 1-2 trial of stereotactic body radiation therapy","volume":"5","author":"Lasley","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.semradonc.2017.04.002_bib41","doi-asserted-by":"crossref","first-page":"E175","DOI":"10.1016\/j.ijrobp.2015.07.997","article-title":"Predictors of liver toxicity following stereotactic body radiation therapy for hepatocellular carcinoma","volume":"93","author":"Velec","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2017.04.002_bib42","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.ijrobp.2004.05.048","article-title":"Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease","volume":"60","author":"Cheng","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2017.04.002_bib43","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1002\/cncr.20591","article-title":"Unexpectedly frequent hepatitis B reactivation by chemoradiation in postgastrectomy patients","volume":"101","author":"Cheng","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2017.04.002_bib44","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ijrobp.2015.11.048","article-title":"Phase 1 trial of sorafenib and stereotactic body radiation therapy for hepatocellular carcinoma","volume":"94","author":"Brade","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2017.04.002_bib45","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.ijrobp.2011.10.020","article-title":"A phase I clinical and pharmacology study using amifostine as a radioprotector in dose-escalated whole liver radiation therapy","volume":"83","author":"Feng","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2017.04.002_bib46","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1182\/blood.V89.6.2184","article-title":"Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation","volume":"89","author":"Salat","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.semradonc.2017.04.002_bib47","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/sj.bmt.1702821","article-title":"Serum hyaluronic acid in patients with veno-occlusive disease following bone marrow transplantation","volume":"27","author":"Fried","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.semradonc.2017.04.002_bib48","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/sj.bmt.1703544","article-title":"Impaired activity of plasma von Willebrand factor-cleaving protease may predict the occurrence of hepatic veno-occlusive disease after stem cell transplantation","volume":"29","author":"Park","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.semradonc.2017.04.002_bib49","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1016\/j.ijrobp.2015.07.271","article-title":"High-serum HGF and low-serum CD40L are associated with liver toxicity after stereotactic body radiation therapy","volume":"93","author":"Cuneo","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2017.04.002_bib50","doi-asserted-by":"crossref","first-page":"S202","DOI":"10.1016\/j.ijrobp.2016.06.504","article-title":"MicroRNAs predict liver toxicity in patients receiving stereotactic body radiation therapy for hepatocellular carcinoma","volume":"96","author":"Cuneo","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2017.04.002_bib51","doi-asserted-by":"crossref","first-page":"e0124795","DOI":"10.1371\/journal.pone.0124795","article-title":"Integrative metabolic signatures for hepatic radiation injury","volume":"10","author":"Kurland","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.semradonc.2017.04.002_bib52","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00534-004-0965-9","article-title":"Assessment of hepatic reserve for indication of hepatic resection: Decision tree incorporating indocyanine green test","volume":"12","author":"Imamura","year":"2005","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.semradonc.2017.04.002_bib53","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijrobp.2007.05.078","article-title":"Liver function after irradiation based on computed tomographic portal vein perfusion imaging","volume":"70","author":"Cao","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2017.04.002_bib54","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.radonc.2014.04.007","article-title":"Estimating functional liver reserve following hepatic irradiation: Adaptive normal tissue response models","volume":"111","author":"Stenmark","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2017.04.002_bib55","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0168-8278(03)00296-4","article-title":"Quantitative liver-spleen scan using single photon emission computerized tomography (SPECT) for assessment of hepatic function in cirrhotic patients","volume":"39","author":"Zuckerman","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.semradonc.2017.04.002_bib56","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.radonc.2015.04.011","article-title":"Differential hepatic avoidance radiation therapy: Proof of concept in hepatocellular carcinoma patients","volume":"115","author":"Bowen","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2017.04.002_bib57","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13550-016-0212-9","article-title":"Measuring total liver function on sulfur colloid SPECT\/CT for improved risk stratification and outcome prediction of hepatocellular carcinoma patients","volume":"6","author":"Bowen","year":"2016","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.semradonc.2017.04.002_bib58","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijrobp.2012.02.037","article-title":"Prediction of liver function by using magnetic resonance-based portal venous perfusion imaging","volume":"85","author":"Cao","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2017.04.002_bib59","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijrobp.2015.09.044","article-title":"Local and global function model of the liver","volume":"94","author":"Wang","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2017.04.002_bib60","doi-asserted-by":"crossref","first-page":"e112731","DOI":"10.1371\/journal.pone.0112731","article-title":"Prospective randomized trial of enoxaparin, pentoxifylline and ursodeoxycholic acid for prevention of radiation-induced liver toxicity","volume":"9","author":"Seidensticker","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semradonc.2017.04.002_bib61","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.3389","article-title":"Unraveling the therapeutic potential of the Hedgehog pathway in cancer","volume":"19","author":"Amakye","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.semradonc.2017.04.002_bib62","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12681","article-title":"Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis","volume":"505","author":"Ding","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.semradonc.2017.04.002_bib63","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3109\/09553002.2014.906766","article-title":"CXCR4 as biomarker for radioresistant cancer stem cells","volume":"90","author":"Trautmann","year":"2014","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.semradonc.2017.04.002_bib64","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw133","article-title":"Radiotherapy for hepatocellular carcinoma: New indications and directions for future study","volume":"108","author":"Ohri","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.semradonc.2017.04.002_bib65","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-2007-1007096","article-title":"Hepatocyte transplantation for the treatment of human disease","volume":"19","author":"Strom","year":"1999","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.semradonc.2017.04.002_bib66","first-page":"5871","article-title":"Amelioration of radiation-induced liver damage in partially hepatectomized rats by hepatocyte transplantation","volume":"59","author":"Guha","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.semradonc.2017.04.002_bib67","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/liv.12507","article-title":"Liver regeneration and energetic changes in rats following hepatic radiation therapy and hepatocyte transplantation by (3)(1)P MRSI","volume":"35","author":"Landis","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.semradonc.2017.04.002_bib68","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jhep.2010.05.010","article-title":"Barriers to the successful treatment of liver disease by hepatocyte transplantation","volume":"53","author":"Soltys","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.semradonc.2017.04.002_bib69","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.ijrobp.2014.02.017","article-title":"Bone marrow-derived stromal cell therapy in cirrhosis: Clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma","volume":"89","author":"Vainshtein","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2017.04.002_bib70","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3727\/096368910X514314","article-title":"Autologous hematopoietic stem cell transplantation in 48 patients with end-stage chronic liver diseases","volume":"19","author":"Salama","year":"2010","journal-title":"Cell Transplant"},{"key":"10.1016\/j.semradonc.2017.04.002_bib71","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/MEG.0b013e32832eb69a","article-title":"Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: A pilot randomized controlled study","volume":"22","author":"Lyra","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.semradonc.2017.04.002_bib72","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1111\/j.1572-0241.2008.01993.x","article-title":"Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis","volume":"103","author":"Pai","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.semradonc.2017.04.002_bib73","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.3748\/wjg.v13.i24.3359","article-title":"Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis","volume":"13","author":"Mohamadnejad","year":"2007","journal-title":"World J Gastroenterol"}],"container-title":["Seminars in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429617300334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429617300334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T00:02:39Z","timestamp":1602892959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053429617300334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":73,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1053429617300334"],"URL":"https:\/\/doi.org\/10.1016\/j.semradonc.2017.04.002","relation":{},"ISSN":["1053-4296"],"issn-type":[{"value":"1053-4296","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation-Induced Liver Toxicity","name":"articletitle","label":"Article Title"},{"value":"Seminars in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semradonc.2017.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}